Manulife Financial Corp (MFC)
(Delayed Data from NYSE)
$29.82 USD
-0.07 (-0.23%)
Updated Oct 8, 2024 04:00 PM ET
After-Market: $29.83 +0.01 (0.03%) 7:14 PM ET
2-Buy of 5 2
A Value D Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$29.82 USD
-0.07 (-0.23%)
Updated Oct 8, 2024 04:00 PM ET
After-Market: $29.83 +0.01 (0.03%) 7:14 PM ET
2-Buy of 5 2
A Value D Growth B Momentum B VGM
Zacks News
Manulife Financial (MFC) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Manulife (MFC) delivered earnings and revenue surprises of -7.58% and 20.55%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
GoHealth (GOCO) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
GoHealth (GOCO) delivered earnings and revenue surprises of -33.33% and 63.43%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Reinsurance Group (RGA) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Reinsurance Group (RGA) delivered earnings and revenue surprises of 177.05% and 2.73%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Manulife Financial (MFC) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Manulife (MFC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are You Looking for a High-Growth Dividend Stock? Manulife Financial (MFC) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Manulife Financial (MFC) have what it takes? Let's find out.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Manulife Financial (MFC) Stock is an Attractive Bet
by Zacks Equity Research
Manulife Financial (MFC) stands to benefit from strategic partnerships, higher margins in annuities and international business, robust capital position and effective capital deployment.
MetLife's (MET) Arm MIM Closes $1.6B Private Equity Fund
by Zacks Equity Research
MetLife's (MET) business MIM used the secondaries market for third-party equity fund. The portfolio includes 80 fund positions across various sectors.
Reasons Why Investors Should Hold Sun Life Financial (SLF)
by Zacks Equity Research
Sun Life Financial (SLF) is well-poised to gain from higher individual life insurance sales, higher real estate valuations and sufficient liquidity.
MetLife (MET) Arm Gets CBI License to Aid European Investors
by Zacks Equity Research
MetLife's (MET) institutional asset management business MIM receives a CBI authorization, which in turn, will help it deliver sound investment capabilities and benefit investors in the EEA.
This is Why Manulife Financial (MFC) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Manulife Financial (MFC) have what it takes? Let's find out.
MFC vs. BRP: Which Stock Is the Better Value Option?
by Zacks Equity Research
MFC vs. BRP: Which Stock Is the Better Value Option?
Reinsurance Group (RGA) Gains From Solid Segmental Growth
by Zacks Equity Research
Reinsurance Group (RGA) holds the potential to reap benefits driven by higher variable investment income, higher invested asset base and prudent capital deployment.
Should You Retain Manulife Financial (MFC) in Your Portfolio?
by Zacks Equity Research
Manulife Financial (MFC) stands to benefit from strategic partnerships, in-force business growth in Canada and Asia and effective capital deployment.
Manulife (MFC) Down 10.6% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Manulife (MFC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Manulife Financial (MFC) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Manulife's (MFC) Q4 Earnings Beat on Solid WAM Business
by Zacks Equity Research
Manulife (MFC) Q4 results reflect expense management in Hong Kong, higher volumes in individual insurance, favorable product mix and strong international sales.
Insurance Stocks' Q4 Earnings on Feb 9: RE, AFG and More
by Tanuka De
Better pricing, exposure growth, solid retention, favorable renewals, reinsurance agreements, and accelerated digitalization likely have favored fourth quarter results of RE, AFG, ACGL, MFC and SLF.
Lincoln National (LNC) Launches Enhanced Version of AssetEdge
by Zacks Equity Research
Lincoln National (LNC) unveils AssetEdge VUL (2022) for offering bundled benefits of added income, varied investment options and death benefit protection.
MFC or SLF: Which Stock is Better-Placed at the Moment?
by Zacks Equity Research
Manulife (MFC) and Sun Life (SLF) are poised to grow in the promising life insurance space. We try to find out which one fares better via comparative evaluation.
Why Should You Retain Manulife (MFC) in Your Portfolio?
by Zacks Equity Research
Manulife (MFC) is poised to grow, given its solid in-force business growth, disciplined expense management, and expanding wealth and asset management business.
Why Is Manulife (MFC) Down 5.3% Since Last Earnings Report?
by Zacks Equity Research
Manulife (MFC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Should You Hold Manulife (MFC) Stock in Your Portfolio?
by Zacks Equity Research
Growing Asia business, expanding Wealth and Asset Management business, cost savings to improve profitability and solid capital position poise Manulife (MFC) to grow.
Manulife (MFC), Venerable Holdings Ink Reinsurance Deal
by Zacks Equity Research
Manulife's (MFC) John Hancock Life Insurance Company (U.S.A.) reinsures about 76% of its legacy U.S. Variable Annuity (VA) block to Corporate Solutions Life Insurance Company, a subsidiary of Venerable.
Manulife (MFC) Q3 Earnings Miss Estimates, Premiums Rise Y/Y
by Zacks Equity Research
Manulife (MFC) Q3 results reflect core investment gains and, higher net fee income from higher average assets under management and administration.